14 Dec 2017 - 15 Dec 2017 / Montpellier, France


The event agendas time zone is CET.

This event plus associated activities on the 14th and 15th of December are free for researchers, academics, doctors and members affiliated with the ONCONET SUDOE Project, its partners and associated partners.

14 Dec 2017
09:00 – 09:30
Main hall
Opening session
  • ONCONET SUDOE coordinator
  • Pôles de compétitivité EUROBIOMED and Cancer-Bio-Santé representatives
  • WP4 coordinator
09:30 – 10:30
Main Hall
Key note speaker

Patrice DENEFLE, Directeur de l’Institut ROCHE de Recherche et de Médicine Translationnelle

10:30 – 11:00
Coffee break
11:00 – 12:30
Main Hall
Session 1: Liquid biopsies as Prognostic biomarkers in solid tumours, new diagnostic approaches and implication in clinical studies

Moderator: Nicolas Reymond, Montpellier Office Project Manage, Eurobiomed.

  • Dra. María José Serrano, Director of Liquid Biopsies Division. Liquid Biopsies & Metastasis Group. Senior Reseach UGC Oncologia. Hospital Virgen de las Nieves. Pfizer - Universidad de Granada - Junta de Andalucía Centre for Genomics and Oncological Research (GENYO)Circulating tumor cells
  • Title: ''Tumor educated platelets and circulating tumor cells as biomarkers to monitoring of prostate cancer patients: Standard operating procedure of Liq BioProst-Granada consortium”
  • Atocha Romero, Hospital Universitario Puerta de Hierro - Head Translational Oncology Lab
  •  Title: "Non-Small Cell Lung Cancer monitoring through liquid biopsy’
  • Artur Paiva, PhD, Centro Hospitalar e Universitário de Coimbra - Head of Flow Cytometry Unit
  • Title: "Contribution of flow cytometry in the identification and characterization of tumor cells in liquid biopsies"

  • Catherine Panabieres, Maître de Conférences des Universités - Praticien Hospitalier au CHU de Montpellier, Directrice du Laboratoire Cellules Circulantes Rares Humaines (LCCRH)
  • Title : "Circulating Tumor Cells : the liquid biopsy of Cancer
  • Gilles Favre, Institut Universitaire du cancer Toulouse Oncopole   
  • Title: ‘’Pending’’  
  • Gabriel Capella, Director, Hereditary Cancer Program, Institut Català d'Oncologia. Director, Bellvitge Biomedical Research Institute
  • Title: ''ctDNA clinical applications: present and future''
  • Hugh Ilyne, CEO and Director at DestiNA Genomics
  • Title: ''Liquid Biopsies and microRNA Biomarkers - Novel PCR free Direct Detection”

                            10 minutes presentation

                            Total of 6 presentations

                             20 min final discussion

12:30 – 14:00
14:00 – 15:40
14:00 – 15:30
Session 2: Microbiome and cancer

Moderator: Fabienne de Toni-Costes, PhD, Project Manager Cancer-Biotechnology Project, Cancer-Bio-Santé.

  • Eduardo Pareja, CEO at Era7 Bioinformatics
  • Title: "Immunogenomics, Microbiome and Cancer Immunotherapy"

  • María Esther Molina, CNIO- Post-Doc Fellow Genetic & Molecular Epidemiology Group
  • Title "Oral/Gut microbiome and pancreatic cancer risk: A complex Tandem’’
  • Jean-Philippe Nougayrède, PhD,  Permanent Researcher at Digestive Health Research Institute, Toulouse
  • Title: ''Gut microbiota and colorectal cancer: is Escherichia coli an enemy within?’’
  • Mariona Serra Pagès, Co-founder and Chief Executive Officer (CEO)
  • Title: ''Fecal bacterial signature  as new method for colorectal cancer screening''
  • Benjamin Lelouvier, Chief Scientific Officer de la société Vaiomer
  • Title: “Analysis of blood microbiome by highly sensitive 16S Metagenomic Sequencing: a new tool for diagnosis.

                         10 minutes presentation

                          Total of 4 presentations

                            20 min final discussion

15:30 – 16:00
Coffee break
16:00 – 17:40
16:00 – 17:30
Session 3: Access to biobank and biological samples in Europe

An opportunity to exchange good practices related to Biobanks, to explore bottle necks in relation to these as well as to promote your biobanks and their related services.

Moderator: Fay Betsou, PhD, HDR - Chief Scientific Officer at IBBL (Integrated Biobank of Luxembourg)

Title: “The Twingo, the Wolseley and the Tesla”

  • Raquel Bermudo Gascón, Raquel Bermudo Gascón, PhD, Coordinadora técnica del Banco de Tumores, Biobanc HCB-IDIBAPS
  • Title: ‘’HCB should stand for Hospital clinic de Barcelona’
  • Manuel Rodríguez Maresca, Scientific Director at Biobank of the Andalusian Public Health System,
  • Title: ''Andalusian Biobank network: A new model''
  • Manuel Morente, CNIO, Head Biobank Unit
  • Title "Access to biobank and biological samples in Europe"
  • Paul Hofman, Professor of Pathology, Nice Hospital Center Head of the Laboratory of Clinical and Experimental Pathology, Pasteur Hospital Nice Director of the Hospital-related Biobank, University Côte d’Azur Team, Leader Inserm , Comprehensive Cancer Center Nice
  • Title: “The Biobank of Nice Côte d’Azur University : Toward a Next Generation Biobank?“
  • Joaquim Pereira, MD, Reumatologist at Hospital Santa Maria, Co-Director of Biobank-IMM
    Title: "Biobanking and cancer"
  • Maya Lauriol, Human samples theme project manager, Canceropôle Grand Sud-Ouest
  • Title : ''A Biobanks collaborative network: an asset to its members and the scientific community''

    Round Table                                                                 
20:00 – 23:00
Centre commercial Odysseum, Allée Ulysse, 34000 Montpellier
Gala Dinner - Aquarium Mare Nostrum
15 Dec 2017
09:00 – 10:30
Session 4: Cancer aggressiveness: understanding the specificity of aggressive cancers in research, diagnosis, treatment and patient care

Moderator: Alicia Utrilla Remesal, Internationalization Technician, Health Technology Park Foundation of Granad.

  • David Olmos, CNIO, Head Prostate Cancer CLinical Research Unit
  • Title: "DNA repair deficient in Prostate Cancer"
  • Henriqueta Breda, MD, PhD, Auxiliary professor of Genetics at Faculty of Medicine of University of Coimbra
  • Title: "Epigenetic signatures and cancer progression"
  • Eva Martinez-Balibrea, PhD, Group LeaderResistance, chemotherapy and predictive biomarkersProCURE program, Catalan Institute of OncologyGermans Trias i Pujol research institute
  • Title: ‘’Searching for useful biomarkers of chemoresistance in metastasic colorectal cancer.’’
  • Dra. María Tabernero, Staff Scientist, IMDEA food Institute
  • Title:"Precision Nutrition and Health Platforms for Cancer Patients''

  • Alboukadel Kassambara, PhD, Institute of Human Genetics, CNRS-UM and University hospital of Montpellier.
  • Title : ''Precision Medicine in Multiple Myeloma : Targeting DNA repair and Epigenetic modifiers to overcome drug resistance.''

                                      10 minutes presentation

                                       Total of 5 presentations

                                         20 min final discussion

10:30 – 11:00
Coffee break
11:00 – 12:40
B&B meetings
11:00 – 12:30
Session 5: Big data and Bioinformatics

Moderator: Angela Moca Licciardi, European project manager,Université Toulouse III - Paul Sabatier.

  • Carlos Cano Gutiérrez, PhD. Adjunct Professor at the University of Granada, Department of Computer Science and Artificial Intelligence and Co-founder of Tanglegen SL
  • Title: ''Big Data in Immunogenetics''
  • Francisco Caramelo, PhD, Assistant Professor of Biophysics at Faculty of Medicine of the University of Coimbra and Co-founder of Spiral Data Lda.
  • Title: "Implementation of a statistical genomic data based model for predicting the recurrence and metastasis development in head and neck squamous cell carcinoma".
  • Fátima Al-Shahrour, CNIO - Head Bioinformatics Unit
  •  Title: "Bioinformatics Challenges for Precision Medicine"
  • Joaquín Dopazo, Clinical Bioinformatics Area Director, Fundación Progreso y Salud,
  • Title:'' The transition from empirical to precision medicine needs genomic big data and systems medicine''
  • Sacha Beaumeunier, Head of Bioinformatics, SeqOne
  • Title: "An optimised environment for building big data models in genomic medicine"

  • Dra Janet Piñero, Research Programme on Biomedical Informatics (GRIB); Hospital del Mar Medical Research Institute (IMIM); Barcelona Biomedical Research Park,
  • Title: ‘’ DisGeNET: A discovery platform to support translational research on human diseases.’
  • Josep Ll. Gelpi, Barcelona Supercomputing Center & Univ. of Barcelona,
  • Title: ‘’ ELIXIR. European infrastructure for bioinformatics’’

                                 10 minutes presentation

                                  Total of 7 presentations 

                                     20 min final discussion

12:30 – 13:30
13:30 – 15:00
Session 6: Innovation, research, funding and market

Moderator: Roi Villar, Head of internationalization, Biocat.

  • Lucas Jurado Fasoli, Nutrition Area Director at ONCODIETA
  • Title: ''"Feeding your health. New approaches in nutrition and cancer"
  • Anabel Sanz, Innovation management director at CNIO
  • Title: "Accelerating Translation of Research into Products: Role of The Techtranfer Office”
  • Ana Catarina Mamede, PhD, founder and CEO of ResearchTrial, Science Communication Agency
  • Title: ''Science Communication: Why?"
  • Marta Soler, PhD , Head of Research and Scientific Debate, Biocat.
  • Title ''Innovating at the edge of collaboration: State of the art of technological partering in Catalonia” 
  • Francisco Ambrósio, PhD, Principal Investigator at Faculty of Medicine of the University of Coimbra
  • Title: "The Research Management Office: The way to leverage YOUR research!"
  • Emmanuel Le Bouder, Innovation project manager, Eurobiomed) and Concepción AVILA, European Funding Advisor, Senior Project Manager – Transferts
  • Title: ‘’Pending’'

                        10 minutes presentation

                       Total of 7 presentations

                        20 min final discussion

15:00 – 15:15
Meeting closure
15:15 – 16:00
Coffee break
15:40 – 18:00
B&B meetings